Wearable technology for the monitoring and improvement of mental health from Lief Therapeutics

The wearable measures an individual’s breath and heart rate to provide real-time stress level monitoring. In addition to real-time monitoring, the technology trains individuals in stress management with biofeedback exercises intended to regulate the body’s natural stress response. The technology is FDA 510(k) cleared and covered by select health insurance plans.

Kheiron Medical Technologies is developing an AI assistant for mammography

Mia (Mammography Intelligent Assessment) combines deep learning technology with over 3 million clinical images to improve confidence in detecting cancer and reduce false positives. The platform is PAC agnostic and supports blinded double reading and single reading workflows. Kheiron has raised over $22.1M in funding to support regulatory approval and commercialization. Some of the key strategics in the mammography market include Fujifilm, Hologic, and Siemens Healthineers.

Vicarious Surgical is combining VR with surgical robotics

The company’s platform will transport surgeons inside the patient to facilitate performing minimally invasive surgery. Vicarious Surgical has raised over $43M in funding, having recently completed a Series A round valued at $13.2M. The technology could help to further accelerate the growth of the robotic surgery market. Accuray, Intuitive Surgical, and Stryker are some of the top competitors in the robotic surgery market.

Conformal Medical raises $70M in Series C round

The company is developing the Conformal Left Atrial Appendage (LAA) seal that conforms to a patient’s anatomy for stroke prevention. The completion of the Series C round brings the company’s total funding to over $79M. Key strategics in the interventional cardiology market include Abbott, Boston Scientific, and Medtronic.

A wireless, smart stethoscope from StethoMe

The StethoMe device utilizes artificial intelligence algorithms to detect abnormalities in the respiratory system. The device can be used by patients and healthcare providers to improve the telemedical process. To-date the company has raised over $6.7M. The company’s device has received the CE Mark.

Laparoscopic lens cleaning device developer ClearCAM raises $2.6M in Seed Round

Funds will be used to support commercialization of the FDA cleared Kelling Device. ClearCam’s Kelling device allows surgeons to clear the lens of the laparoscope without withdrawing the scope from the body during surgery. Strategics in the laparoscopic devices market include Karl Storz, Olympus, and Stryker.

Learn about the hottest venture funded startups developing innovative medical technologies using Life Science Intelligence’s Medtech Start-Up Tracker.